The US Food and Drug Administration (FDA) admonished Sun Pharmaceutical Industries in a recent warning ... These violations prompted FDA to place the firm on import alert on 7 December. FDA inspected ...

In a warning letter, the FDA has highlighted a series of lapses at Sun Pharma’s Gujarat plant, which has been put on an import alert list by the US drug regulator. In the letter dated December ...

the FDA has highlighted a series of lapses at Sun Pharma’s Gujarat plant, which has been put on an import alert list by the US drug regulator.#sunpharma #halolfacility #usfda #cnbctv18 # ...

For the US import alert to be lifted, Sun Pharma must conduct an independent, retrospective assessment of its cleaning effectiveness and cross-contamination hazards. The company was given 15 working ...

Sun Pharmaceutical Industries, a leading Indian pharma giant with revenues of over Rs. 38,400 crore plus, has posted consolidated revenue growth of 14 per cent during the third quarter ended December ...

Sun Pharmaceutical Industries posted a 5.2 percent year-on-year (YoY) rise in net profit for the third quarter of Financial Year 2022-23 to Rs 2,166 crore, riding on the back of sales in India and the ...

India's largest drugmaker Sun Pharmaceuticals Ltd. is likely to report a healthy quarter despite the weakness from its ...

Sun Pharma and Concert expect to complete the transaction later in the current quarter. If deuruxolitinib reaches the market, it would compete against Eli Lilly’s Olumiant, which the FDA ...

Sun Pharmaceutical Industries Ltd , India's largest drugmaker by revenue, reported a better-than-expected 5.2% rise in ...

Global Pharma Healthcare Private Limited produces artificial tears that are sold under the brand names EzriCare or Delsam ...

The suit accuses LGM Pharma LLC, headquartered at 6400 Congress ... The company also imported ingredients from suppliers on the FDA’s Import Alerts list, which gives the agency authority to ...